Login

Switch On Your HIV Smarts.

Dolutegravir Looks Good in Another Advanced Clinical Trial

Dolutegravir Looks Good in Another Advanced Clinical Trial

, by Reilly O'Neal

Learn more about this next-generation integrase inhibitor and see how it stacks up against popular HIV drug regimen Atripla. Read More

Reducing Inflammation: Do Some HIV Drugs Work Better Than Others?

Reducing Inflammation: Do Some HIV Drugs Work Better Than Others?

, by San Francisco AIDS Foundation

New research suggests starting antiretroviral treatment reduces inflammation caused by HIV infection—but plenty of questions remain. Read More

AIDS 2012: D.C. Declaration Maps Route to Ending AIDS

AIDS 2012: D.C. Declaration Maps Route to Ending AIDS

, by Reilly O'Neal

“The goal of beginning to end the AIDS epidemic is ambitious, but achievable. It is within our grasp.” Learn about a new call to action for everyone working to end HIV/AIDS. Read More

Ask a Guinea Pig: What Do I Need to Know Before Joining a PrEP Trial?

Ask a Guinea Pig: What Do I Need to Know Before Joining a PrEP Trial?

, by Matt Sharp

BETA's new column shares an insider perspective on taking part in clinical trials. Thinking of joining a study of PrEP—a pill a day for HIV prevention? Start here. Read More

FDA Approves First At-Home Rapid HIV Test

FDA Approves First At-Home Rapid HIV Test

, by Reilly O'Neal

The first over-the-counter rapid HIV test will be available in October. Read on for news and views on this newly approved HIV testing option. Read More